Andrew M. Evens, DO,MBA,MSc

An international expert in lymphoma, Dr. Evens serves as the Deputy Director for Clinical Services and Chief Physician Officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center and System Director of Medical Oncology and Oncology Lead, RWJBarnabas Health Medical Group. His research interests including novel targeted therapeutic agents, predictive modeling, and precision medicine. He completed a fellowship in hematology/oncology at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center in Chicago, Illinois, where he was a faculty member for 11 years. He then served as the director of the Cancer Center and chief of hematology/oncology at Tufts Medical Center in Boston. His clinical expertise and research interests are focused in the field of lymphoid malignancies, in particular Hodgkin lymphoma and non-Hodgkin lymphoma. He has been the principal investigator of more than 100 cancer clinical trials that have and has led several national and global health outcomes and data analytics projects in lymphoma. His research has been continuously funded by the National Institutes of Health since 2005. This has resulted in 400+ research abstract presentations at national and international cancer symposiums, 230+ manuscripts in peer-reviewed publications, and 40+ book chapters with an emphasis on the prognosis, treatment, and health outcomes of cancer. Dr. Evens has received numerous honors and awards and holds leadership positions in a number of international organizations and is the Chair of the Lymphoma Research Foundation.

Clinical Interests:

Hodgkin lymphoma, non-Hodgkin lymphoma (all types), chronic lymphocytic leukemia, and autologous hematopoietic stem cell (or bone marrow) transplantation